reviewTop 1% cited
Systematic review with meta‐analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome
Alimentary Pharmacology & Therapeutics · 2019 · Vol. 50(2) · pp. 132–143
Mohammad Zamani✉(Babol University of Medical Sciences)Shaghayegh Alizadeh‐Tabari(Babol University of Medical Sciences)Vahid Zamani(Babol University of Medical Sciences)
Abstract
Patients with IBS have a three-fold increased odds of either anxiety or depression, compared to healthy subjects.
Gastrointestinal motility and disordersMusic Therapy and HealthPathogenesis and Treatment of HiccupsIrritable bowel syndromeMedicineAnxietyDepression (economics)Odds ratioInternal medicineMeta-analysisFunctional gastrointestinal disorderPsychiatry
MeSH terms
AdolescentAdultAgedAged, 80 and overAnxietyAnxiety DisordersDepressionDepressive DisorderFemaleHumansMaleMiddle AgedPrevalenceOdds RatioIrritable Bowel Syndrome
Citations
452
FWCI
25.35
field-weighted impact
References
106
Percentile
100%
vs. same field & year
Citations per year
References
Review article: the economic impact of the irritable bowel syndrome
Alimentary Pharmacology & Therapeutics · 2014 · 446 citations
Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement
Journal of Clinical Epidemiology · 2012 · 2,512 citations
Measuring inconsistency in meta-analyses
BMJ · 2003 · 61,700 citations
Quantifying heterogeneity in a meta‐analysis
Statistics in Medicine · 2002 · 36,106 citations
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
BMJ · 2009 · 82,871 citations
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
PLoS Medicine · 2009 · 63,014 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
